IMTX Stock Analysis: Buy, Sell, or Hold?
IMTX - Immatics N.V. Ordinary Shares
$9.35
0.12 (1.30%)
▲
5d:
-8.87%
30d:
+3.2%
90d:
-13.98%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 12, 2026
28d
Get Alerted When IMTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMTX is currently trading at $9.35, which is considered slightly low relative to its 30-day fair value range of $9.25 to $9.98.
Technical Outlook: Technically, IMTX is showing sideways momentum. The price is currently testing key support at $9.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IMTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.89 (+104.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMTX is showing sideways momentum. The price is currently testing key support at $9.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IMTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.89 (+104.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.25 -
$9.98
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 104.6% below Wall St target ($18.89)
- CAUTION: 5-day price weakness (-8.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$9.25 -
$9.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$9.10
Resistance Level
$10.89
Current Trend
Sideways
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.85
Wall Street Target
$18.89
(+104.6%)
Revenue Growth (YoY)
-59.0%
Share & Embed Analysis
Last updated: July 14, 2026 2:12 PM ET
Data refreshes hourly during market hours. Next update: 3:12 PM
Data refreshes hourly during market hours. Next update: 3:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 60 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
